20 results
Thumbnail

D1.349 - Early Diagnosis of WHIM Syndrome in Infancy: A Case with a De Novo CXCR4 Mutation

Thumbnail

D1.348 - Retrospective Evaluation of Laboratory and Clinical Characteristics of Pediatric Patients Diagnosed with IgG Subclass Deficiency and Receiving Intravenous Immunoglobulin Replacement Therapy

Thumbnail

D1.350 - Selective IgA deficiency and its association with allergic and autoimmune diseases

Thumbnail

D1.351 - Chronic urticaria and autoimmunity: clinical, laboratory and molecular associations

Thumbnail

D1.353 - A Rare Cause of Recurrent Infections: SIFD Syndrome

Thumbnail

D1.354 - Possible Association of a MYOF Loss-of-Function Variant With Recurrent Angioedema: Overlap Between Chronic Spontaneous Urticaria and Normal-C1 Hereditary Angioedema? A Case Report

Thumbnail

D1.355 - Familial Recurrent Angioedema with Normal C1-Inhibitor: A Clinical Case Series Suggestive of HAE with Normal C1-INH

Thumbnail

D1.356 - Atypical association of anti-EJ and anti-RNA polymerase III antibodies in a patient referred for interstitial lung disease

Thumbnail

D1.357 - Atypical case of common variable immune deficiency with granulomatous lymphocytic interstitial lung disease

Thumbnail

D1.363 - Long-Acting Prophylactic Injection BW-20805: Remarkable and Sustained HAE Attack Reduction — Updated Analysis from an Ongoing Phase 2 Study

Thumbnail

D2.165 - Geographic Disparities in Air Pollution and Th2-Mediated Airway Inflammation in Pediatric Asthma: A Cross-Sectional Study from Mexico City

Thumbnail

D2.167 - Impact of body mass index on oscillometry parameters in children with respiratory symptoms

Thumbnail

D2.168 - Impact of type two inflammation inflamation suppression on polyp burden in patients with nasal polyposis and concomitant asthma a comparative evaluation of biologic therapies

Thumbnail

D2.171 - Clinical and demographic characteristics associated with a classification as difficult-to-treat asthma: data from the EPI-ASTHMA study

Thumbnail

D2.172 - Effectiveness of Mepolizumab in patients with severe asthma and allergic rhinitis: Real-World Evidence from the TYREX Study

Thumbnail

D2.173 - Real-World Evidence From the TYREX Study on the effectiveness of Mepolizumab in patients with severe asthma and clinically relevant aeroallergen sensitization

Thumbnail

D2.174 - Association Between Environmental Conditions and Mold Sensitization in Children with Allergic Rhinitis and Asthma

Thumbnail

D2.175 - Five-Year Real-World Outcomes of Mepolizumab Treatment in Severe Eosinophilic Asthma

Thumbnail

D2.176 - Comparison of different treatment strategies for allergic rhinitis in children and their impact on bronchial asthma

Thumbnail

D2.179 - Chronic cough triggered by industrialised milk and wheat products